Refeeding syndrome complete guide for emergency physician

Reading File

Finding Sources

Searching PubMed

"refeeding syndrome" AND management

Searching the Web

refeeding syndrome emergency medicine management 2024 2025 guidelines

Reading File

Reading Web Page

https://emcrit.org/ibcc/refeeding

Reading File

Finding Sources

Reading Article

PMID: 40090863

Loading Image

Reading File

Finding Sources

I now have enough data from multiple authoritative sources to build a comprehensive guide. Let me compile it:

Refeeding Syndrome: Complete Guide for the Emergency Physician

1. Definition

Refeeding syndrome (RFS) is a potentially fatal metabolic disorder caused by the reintroduction of nutrition - oral, enteral, or parenteral - to patients who have been significantly malnourished or starved. It is characterized by severe fluid and electrolyte derangements, typically occurring within 72 hours of nutrition reintroduction.

The syndrome was first described after World War II, when severely malnourished Japanese prisoners were refed and developed sudden electrolyte crises and death. - Yamada's Textbook of Gastroenterology, 7th ed.

2. Pathophysiology

The core mechanism involves a critical metabolic shift from fat-based to carbohydrate-based fuel metabolism after refeeding.

During starvation:

Fatty acids and amino acids become the primary fuel sources
Insulin levels fall
Intracellular minerals (phosphate, potassium, magnesium) are progressively depleted
Serum electrolyte levels can appear deceptively normal because bone stores maintain serum levels

On refeeding (the trigger):

Carbohydrate load stimulates insulin secretion
Insulin activates Na/K-ATPase - driving potassium (and phosphate, magnesium) into cells
Phosphate is consumed intracellularly to synthesize ATP via glycolysis
Thiamine (vitamin B1) is consumed as a cofactor for pyruvate dehydrogenase; without it, pyruvate cannot enter the Krebs cycle
Sodium and water are retained, causing volume expansion

Result: Rapid and severe drops in serum phosphate (hallmark), potassium, and magnesium - all occurring against a background of total body depletion of these electrolytes. - Schwartz's Principles of Surgery, 11th ed.; Yamada's GI, 7th ed.

3. Who is at Risk? (NICE/ASPEN Criteria)

High Risk (ONE criterion sufficient - NICE 2006):

Criterion	Threshold
BMI	< 16 kg/m²
Unintentional weight loss	> 15% in last 3-6 months
Little or no nutritional intake	> 10 days
Pre-existing low electrolytes	Potassium, phosphate, or magnesium LOW before feeding

Moderate Risk (TWO criteria needed):

Criterion	Threshold
BMI	16-18.5 kg/m²
Unintentional weight loss	> 10% in last 3-6 months
Little or no nutritional intake	> 5 days
History of: alcohol abuse, insulin use, chemotherapy, antacids, or diuretics

ASPEN Moderate/Significant Risk Table (Tietz Textbook of Laboratory Medicine, 7th ed.):

Category	Moderate Risk (2 criteria)	Significant Risk (1 criterion)
BMI	16-18.8 kg/m²	< 16 kg/m²
Weight loss	5% in 1 month	7.5% in 3 months OR >10% in 6 months
Caloric intake	< 75% of needs for > 7 days	< 50% of needs for > 5 days
Electrolytes	Minimally low or recently low requiring single-dose replacement	Moderately/significantly low or requiring multi-dose replacement
Comorbidities	Moderate disease, AIDS, cancer, chronic alcohol, post-bariatric	Severe loss/disease

Key Clinical Populations to Screen in the ED:

Anorexia nervosa / eating disorders (highest risk, also have QT prolongation)
Chronic alcoholism
Prolonged NPO patients (post-op, ICU)
Cancer patients on chemotherapy
Post-bariatric surgery patients
Patients with prolonged diarrhea or high-output fistulas
Obese patients with massive recent weight loss
Prisoners on hunger strike
Homeless / severely socially deprived individuals

4. Clinical Presentation

Timing: Symptoms typically begin 24-72 hours after refeeding initiation.

Organ System Breakdown:

System	Manifestation
Cardiac	Arrhythmias (VT/VF), heart failure, edema, bradycardia (especially in anorexia)
Respiratory	Respiratory muscle weakness, failure to wean from ventilator, respiratory failure
Neurological	Confusion, encephalopathy, seizures, Wernicke's encephalopathy (thiamine deficiency), peripheral neuropathy
Musculoskeletal	Profound weakness, rhabdomyolysis
Hematologic	Hemolytic anemia, leukocyte dysfunction, platelet dysfunction
GI	Ileus, constipation
Metabolic	Hyperglycemia (from blunted insulin response in some), lactic acidosis
Fluid	Sodium and water retention, edema, acute volume overload

The most severe presentations = cardiac arrhythmia or respiratory arrest. - Bailey & Love's Surgery, 28th ed.; Current Surgical Therapy, 14th ed.

5. Laboratory Abnormalities

Hallmark Finding:

Hypophosphatemia - the sine qua non of RFS. Levels can drop precipitously within hours of feeding. Severe = < 0.5 mmol/L (< 1.5 mg/dL).

Full Electrolyte Picture:

Electrolyte	Direction	Why
Phosphate	↓↓ (hallmark)	Intracellular shift for ATP synthesis
Potassium	↓	Na/K-ATPase activation by insulin
Magnesium	↓	Intracellular shift (mechanism incompletely understood); worsens hypokalemia
Calcium	↓	Linked to hypomagnesemia (impairs PTH release)
Glucose	↑ or ↓	Hyperglycemia from stress response; hypoglycemia risk if insulin excess
Sodium	Variable	Water retention can cause dilutional hyponatremia

Other labs to order:

ABG: lactic acidosis, respiratory compromise
CK: rhabdomyolysis
ECG: QT prolongation, arrhythmia detection
Thiamine level (if available, but do not wait for result before dosing)
LFTs, renal function, glucose

6. Clinical Definitions

ASPEN Definition (2020): RFS is diagnosed when the patient has had adequate nutrition intake (≥ 50% of estimated requirements), AND electrolyte imbalances and clinical symptoms emerge after its commencement. It should NOT be diagnosed from electrolyte changes alone without clinical correlation.

Practical ED definition: A drop of ≥ 30% in serum phosphate (or absolute level < 0.6 mmol/L) within 72 hours of refeeding, with or without clinical symptoms.

7. Emergency Management

Step 1: Identify at-risk patients BEFORE feeding

In the ED, screen every malnourished patient before initiating IV dextrose, enteral feeds, or TPN. Even a dextrose-containing IV bag can trigger RFS in a severely malnourished patient.

Step 2: Pre-refeeding workup

Electrolytes (Na, K, Mg, Phos, Ca)
Blood glucose
Renal function
ECG
Thiamine level (order but don't wait)

Step 3: Thiamine FIRST

Give thiamine 100 mg IV BEFORE any glucose or carbohydrate. This is non-negotiable. Without thiamine, glucose loading causes Wernicke's encephalopathy (and precipitates lactic acidosis via pyruvate dehydrogenase blockade). - Tietz Lab Medicine, 7th ed.

Standard: thiamine 100 mg IV x1 before feeds, then daily for 5-7 days
High-risk (severe starvation, alcoholism): continue 100 mg IV daily x 5-7 days

Step 4: Correct pre-existing electrolyte deficits BEFORE or alongside feeding

Restore phosphate, potassium, and magnesium to normal before initiating significant caloric load.

Step 5: Start feeds slowly

Risk Level	Initial Rate	Goal
Moderate risk	10-20 kcal/kg/day	Increase gradually to full requirements over 4-7 days
High risk	Maximum 10 kcal/kg/day	Increase to 20 kcal/kg over 48h, then slowly to full needs
Highest risk (prolonged starvation, fistula losses)	< 10 kcal/kg/day OR 50% of estimated needs day 1	Reach full needs over 5-7 days

For parenteral nutrition: start with only 50% of the dextrose on day 1. - Yamada's GI, 7th ed.

Important 2025 update (AuSPEN Consensus): There is no evidence that patients at risk need to START at a lower-than-standard enteral feed rate for checking tolerance. Goal rates should be reached within 24-72 hours for most routes of nutrition. The key is close monitoring and electrolyte replacement, not necessarily severe caloric restriction for all patients.

Step 6: Electrolyte monitoring and replacement

Monitoring schedule:

Electrolytes (phosphate, potassium, magnesium, calcium) at baseline, then at 6-12h after initiating feeds
High-risk: twice-daily electrolytes for first 3 days
Blood glucose every 4-6 hours initially

Replacement thresholds (approximate - follow local protocol):

Electrolyte	Mild low	Moderate low	Severe low
Phosphate	0.6-0.8 mmol/L - oral replacement	0.4-0.6 mmol/L - IV replacement, slow feeds	< 0.4 mmol/L - aggressive IV, consider stopping feeds briefly
Potassium	3.0-3.5 mEq/L - oral KCl	2.5-3.0 mEq/L - IV replacement	< 2.5 mEq/L - continuous IV monitoring
Magnesium	0.6-0.7 mmol/L - oral/IV	< 0.6 mmol/L - IV replacement	Refractory hypokalemia = suspect and treat hypoMg first

Note: Hypomagnesemia will make hypokalemia refractory to replacement. Fix magnesium before potassium.

Step 7: Multivitamin supplementation

Give a multivitamin and trace elements daily for at least the first week of refeeding. B-complex vitamins are particularly important.

8. Established RFS: Treatment

If RFS develops after feeding has been started:

Reduce or temporarily hold feeds - do not stop feeds entirely unless severe, as abrupt cessation causes hypoglycemia
Aggressive IV electrolyte repletion - phosphate, potassium, magnesium simultaneously
Continue thiamine supplementation
Cautious insulin use - insulin further drives electrolytes into cells; use only for significant hyperglycemia (> 10-12 mmol/L) and with great care
Manage volume overload - diuretics must be used with extreme caution (worsen potassium/magnesium losses); fluid restriction preferred
Monitor and treat arrhythmias - ECG monitoring, correct electrolytes aggressively
Respiratory support if muscle weakness causes ventilatory failure
Treat rhabdomyolysis - IV fluids, monitor renal function and CK

9. ED-Specific Pitfalls

Pitfall	Consequence	Fix
Starting dextrose IV in alcoholic without thiamine	Precipitates Wernicke's encephalopathy	Always give thiamine first
Normal electrolytes = no risk	False security - bone stores maintain serum levels until they collapse	Screen history + signs, not just labs
Assuming only TPN causes RFS	Even oral feeding, enteral nutrition, or dextrose-containing IV fluids can trigger it	Screen any nutritional input
Aggressive insulin for hyperglycemia in malnourished patient	Worsens intracellular electrolyte shift	Use insulin cautiously; fix electrolytes first
Correcting hypokalemia without correcting hypomagnesemia	Refractory hypokalemia	Correct Mg first or concurrently
Rapid hyponatremia correction in eating disorder patient	Osmotic demyelination syndrome	Correct slowly, < 8-10 mEq/L per 24h
QT prolongation in anorexia patients	Fatal ventricular arrhythmias	ECG in all eating disorder admissions; aggressive electrolyte correction

10. Prognosis and Mortality

A 2021 systematic review and meta-analysis (PMID 33864767) confirmed RFS is associated with significant short- and medium-term all-cause mortality. Patients who develop actual RFS (as opposed to just electrolyte shifts) have substantially worse outcomes. The 2026 systematic review on risk prediction models (PMID 41793849) notes that ICU patients are at highest risk and that current risk models remain inadequately validated.

11. Quick Reference Card for the ED

SCREEN → Any malnourished patient getting feeds/IV dextrose
         ↓
LABS   → BMP + Mg + Phos + ECG before starting
         ↓
THIAMINE → 100 mg IV BEFORE any glucose (non-negotiable)
         ↓
FIX LYTES → Correct K, Phos, Mg before or with feeding start
         ↓
START LOW → 10-20 kcal/kg/day max; 50% of EN rate day 1 for high risk
         ↓
MONITOR  → Electrolytes q6-12h for first 72h; daily thereafter
         ↓
MULTIVIT → Thiamine + B-complex + trace elements daily x 1 week
         ↓
ESCALATE → If levels falling: reduce feeds, replace IV aggressively,
           cardiac monitor, consider ICU

Sources:

Bailey and Love's Short Practice of Surgery, 28th ed. - risk criteria, clinical features
Schwartz's Principles of Surgery, 11th ed. - mechanism, management
Current Surgical Therapy, 14th ed. - definition, timing, electrolyte pattern
Yamada's Textbook of Gastroenterology, 7th ed. - pathophysiology diagram, management steps
Tietz Textbook of Laboratory Medicine, 7th ed. - ASPEN risk stratification table, thiamine dosing
AuSPEN Consensus 2025 (PMID 40090863) - updated guidance on feeding rates and diagnosis
RFS mortality meta-analysis 2021 (PMID 33864767) - mortality impact
EMCrit IBCC - Refeeding Syndrome (Josh Farkas, 2024) - EM-focused clinical framework

Damage control Resuscitation

Reading File

Finding Sources

Searching PubMed

"damage control resuscitation" AND trauma

Searching the Web

damage control resuscitation trauma 2024 2025 guidelines ATLS hemorrhagic shock

Reading File

Searching PubMed

tranexamic acid trauma hemorrhage mortality

Reading File

Loading Image

Reading File

Finding Sources

Reading Article

PMID: 40842057

Reading File

Finding Sources

I now have comprehensive data from multiple authoritative sources. Let me compile the complete guide:

Damage Control Resuscitation (DCR): Complete Guide for the Emergency Physician

1. Concept and Historical Context

Damage Control Resuscitation (DCR) - also called hemostatic resuscitation - is the modern paradigm for managing hemorrhagic shock in critically injured trauma patients. It replaced the historical approach of aggressive crystalloid-based resuscitation, which was associated with dramatically worse outcomes.

Origins: DCR emerged from military medicine in the 2000s (Iraq/Afghanistan conflicts), where fresh whole blood was used empirically in massively bleeding casualties. The success of military experience drove its translation to civilian trauma.

The core insight: While a patient is still actively bleeding, no aspect of the shock state - blood pressure, end-organ perfusion, temperature, or lactic acidosis - can be corrected by pouring in clear fluids. Volume resuscitation with crystalloids before hemostasis actively worsens coagulopathy, hypothermia, and acidosis. - Bailey and Love's Surgery, 28th ed.

ATLS 11th edition (2025) formalizes DCR as a core principle and introduces the xABCDE sequence - placing control of exsanguinating hemorrhage (x) before airway management, recognizing uncontrolled hemorrhage as the leading cause of preventable trauma death.

2. The Lethal Triad - Understanding What You're Fighting

The three mutually reinforcing killers in hemorrhagic trauma:

        HYPOTHERMIA
           ↓  ↑
    (worsens coagulation factor activity,
     platelet function; reduces cardiac output)
            ↗      ↘
COAGULOPATHY  ←→  ACIDOSIS
(tissue hypoxia,     (dilutional, lactic;
 dilution, factor    further impairs
 consumption)        coagulation cascades)

Hypothermia (core temp < 35°C): impairs coagulation factor activity and platelet function
Acidosis (pH < 7.2): platelet morphology changes, declining factor activity, decreased thrombin generation
Coagulopathy: results from tissue injury, dilution from crystalloids, consumption of factors, and hyperfibrinolysis

Large-volume crystalloid resuscitation before hemostasis directly causes all three legs of the lethal triad. DCR is specifically designed to prevent their development. - Mulholland & Greenfield's Surgery, 7th ed.

3. Four Pillars of DCR

Damage control resuscitation vs perfusion-targeted resuscitation

DCR applies only while the patient is actively bleeding. Once haemostasis is achieved, the strategy shifts to perfusion-targeted resuscitation. - Bailey and Love's Surgery, 28th ed.

Pillar 1: Rapid Hemorrhage Control (Stop the Bleeding First)

This is the overriding priority at every moment.

Location	Intervention
External extremity	Tourniquet (high and tight, 2-3 inches above wound)
Junctional (groin, axilla, neck)	Wound packing with hemostatic gauze + direct pressure
Pelvis	Pelvic binder
Intracavitary (chest/abdomen)	Immediate OR / damage control surgery
Non-compressible torso hemorrhage	REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) - at select centers

In the abdomen (Damage Control Surgery): Pack, control bleeding, limit contamination, leave abdomen open, bring to ICU. Definitive repair is deferred. Standard criteria: major abdominal vascular injury + any two of: coagulopathy, acidosis, hypothermia.

Pillar 2: Permissive Hypotension

The concept: Deliberately accept a lower-than-normal blood pressure until surgical hemostasis is achieved. Aggressive fluid resuscitation raises blood pressure, which can "pop the clot" and worsen hemorrhage.

Parameter	Target
Systolic BP (penetrating trauma)	80-90 mmHg
MAP (general)	~50-65 mmHg
Duration	Only until definitive hemorrhage control

Critical exceptions - do NOT use permissive hypotension in:

Traumatic brain injury (TBI) - cerebral perfusion pressure must be maintained; MAP > 80 mmHg
Elderly patients - more likely to have cardiac and carotid disease; hypotension causes catastrophic ischemia
Blunt trauma (relative caution vs. penetrating)
Spinal cord injury

Mulholland & Greenfield's Surgery, 7th ed.

Pillar 3: Hemostatic Resuscitation (Blood Products, Not Crystalloids)

Minimize crystalloids. Crystalloids dilute clotting factors and cause dilutional coagulopathy, hypothermia, and abdominal compartment syndrome.

Use blood products early, in balanced ratios.

The 1:1:1 Ratio (PROPPR Trial)

FFP : Platelets : pRBCs = 1:1:1
This approximates whole blood's coagulation function
The landmark PROPPR RCT (Holcomb et al., JAMA 2015) showed 1:1:1 vs 1:1:2 reduced 24-hour and 30-day mortality and increased rates of hemostasis
More recent evidence confirms improved survival with 1:1 plasma:pRBC ratios, especially when given in the first 6-12 hours

Whole Blood (WB)

If available: low-titer cold-stored whole blood is superior to component therapy (provides all elements in physiologic ratios)
Used routinely in military settings; increasingly available in civilian trauma centers
The gold standard when available; component therapy is a substitute

Cryoprecipitate

Rich in fibrinogen, Factor VIII, vWF, Factor XIII
Used as adjunct when hyperfibrinolysis depletes fibrinogen
Also acts as low-volume colloid
Fibrinogen target: > 1.5-2.0 g/L

Calcium Replacement

Massive transfusion causes citrate chelation of calcium - profound hypocalcemia worsens cardiac function and coagulation
Give calcium chloride 1g IV after every 4 units of blood products, or as guided by iCa++
Target ionized calcium > 1.1 mmol/L

The Role of Hypertonic Saline

Draws water into vascular space with small volume (especially 7.5% or 5% NaCl)
Potential immune-modulating effects reducing resuscitation injury
Theoretical advantages in TBI (reduces cerebral edema)
A multicenter RCT was halted early due to no survival difference; small subset without transfusion requirement had higher mortality with HTS
Current use: limited; considered as a one-time bolus in select patients, particularly TBI

Pillar 4: Treating Existing Coagulopathy

Tranexamic Acid (TXA) - The Most Important Drug in DCR

Mechanism: Antifibrinolytic - blocks plasminogen binding to fibrin, preventing clot breakdown. Trauma causes acute hyperfibrinolysis in 20-30% of patients.

Dosing:

1g IV over 10 minutes within 3 hours of injury, followed by 1g IV over 8 hours (CRASH-2 protocol)
Alternative (NAEMSP/ACEP/ACS-COT 2025): 2g IV push (single dose, prehospital friendly)
Must be given within 3 hours of injury - after 3 hours, TXA is ineffective and may increase mortality

Evidence:

CRASH-2 trial (20,000+ patients): relative reduction in all-cause mortality and hemorrhage death
2024 meta-analysis (PMID 37999653): TXA reduces mortality in traumatic hemorrhage in emergency settings
2025 EAST PMG (PMID 40956301): strong evidence supporting TXA in injured patients at risk of hemorrhage
2025 Joint Position Statement - NAEMSP/ACEP/ACS-COT (PMID 40842057): recommends prehospital TXA for hemorrhagic shock, either 1g + 1g or 2g dose, within 3 hours

TXA in the ED: Give immediately at triage in any patient with hemorrhagic shock - do not wait for labs. Time to administration matters more than precise timing.

Prothrombin Complex Concentrate (PCC) and rFVIIa

4-factor PCC (25-50 units/kg): rapid reversal of anticoagulant-associated coagulopathy; cost-effective second-line agent in MTP
rFVIIa: activates Factor Xa at injury site via tissue factor on platelets; early studies promising but larger RCTs did not confirm mortality benefit; role now limited to refractory coagulopathy
FFP (preferred first line over PCC in most civilian protocols)

4. Massive Transfusion Protocol (MTP)

An MTP is a predefined, activated protocol that brings blood products rapidly to the bedside in pre-packaged cooler packs (typically in 1:1:1 ratios). Implementing an MTP is now required by the American College of Surgeons for all verified trauma centers.

Predicting the Need for MTP - Scoring Tools

Score	Variables	Threshold for MTP Activation
ABC Score (Assessment of Blood Consumption)	HR > 120, SBP ≤ 90, penetrating mechanism, FAST positive	≥ 2 points = activate
TASH Score	Hgb, SBP, HR, FAST, fracture, lactate, sex	≥ 16 = high probability
Clinical gestalt	Transient or non-responder to initial resuscitation	Activate early, don't wait

Key principle: Activate MTP early and based on mechanism + hemodynamics. Do not wait for lab results. De-escalate once hemostasis achieved and labs guide further therapy.

5. Viscoelastic Testing: TEG and ROTEM

Conventional coagulation tests (PT, aPTT, INR) are unreliable in trauma - they are performed at physiologic pH and temperature, failing to account for the effects of hypothermia and acidosis on in-vivo coagulation. They also cannot detect hyperfibrinolysis.

Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM) are point-of-care viscoelastic tests that:

Provide a dynamic real-time view of clot formation, strength, and lysis
Detect coagulation factor deficiencies, platelet dysfunction, and fibrinolysis
Give results in 5-15 minutes
Guide targeted resuscitation - reduce unnecessary blood product use and direct specific factor replacement
Are more accurate than conventional labs in predicting massive transfusion requirements

Mulholland & Greenfield's Surgery, 7th ed.; Morgan & Mikhail's Clinical Anesthesiology, 7th ed.

TEG Parameter	Deficit	Product to Give
Prolonged R-time	Factor deficiency	FFP
Prolonged K-time / Low alpha angle	Fibrinogen deficit	Cryoprecipitate
Low MA (max amplitude)	Platelet dysfunction	Platelets
Elevated LY30 / Clot lysis	Fibrinolysis	TXA
Hypercoagulable pattern	Clot present, bleeding controlled	Adjust ratios down

When TEG/ROTEM is available: transition from empiric 1:1:1 to goal-directed component therapy once bleeding is controlled.

6. Endpoints of Resuscitation

Vital sign normalization is not sufficient. Up to 82% of severely injured patients with normalized vital signs have ongoing occult ischemia. - Mulholland & Greenfield's Surgery, 7th ed.

Endpoint	Target	Notes
Lactate	< 2 mmol/L (trending down)	Best marker of oxygen debt clearance
Base deficit	> -6 mEq/L	Severity correlates with mortality
pH	> 7.35
Temperature	> 36°C	Active warming throughout
Ionized calcium	> 1.1 mmol/L	Replace aggressively
Fibrinogen	> 1.5-2.0 g/L
Urine output	> 0.5 mL/kg/hr	Only after hemorrhage controlled
Mixed venous O2 (SvO2)	> 65%	Even with normal vitals - detects ongoing shock
Platelet count	> 50,000/µL (> 100,000 if TBI)
INR	< 1.5

7. Managing the Lethal Triad Specifically

Hypothermia (core temp < 35°C)

Remove all wet clothing immediately
Warm all IV fluids (blood products through fluid warmer - mandatory for high-volume transfusion)
Warm IV fluids and blood products: target > 37°C infusion temperature
External warming blankets (Bair Hugger)
Warm humidified oxygen
Warm the resuscitation bay
Rewarming via warmed peritoneal lavage or CRRT in extreme cases

Acidosis

Treat the cause (hemorrhage control + restore perfusion)
Bicarbonate not recommended as primary therapy - does not correct underlying tissue hypoxia and can worsen cellular acidosis
Correct with restoration of perfusion (lactate clearance is the guide)

Coagulopathy

TXA early
Balanced blood products (1:1:1)
Calcium replacement
Cryoprecipitate if fibrinogen low
Warm products to prevent worsening hypothermia-driven coagulopathy
TEG/ROTEM guided therapy once available

8. ED-Specific Workflow

SCENE / PREHOSPITAL
  ├─ Tourniquet / wound pack / pelvic binder
  ├─ TXA 1g IV (or 2g) if shock + < 3h from injury
  └─ Minimum fluids (no crystalloid boluses)
         ↓
TRAUMA BAY ARRIVAL (xABCDE - ATLS 11)
  x → Control exsanguinating hemorrhage FIRST
  A → Airway
  B → Breathing
  C → Circulation (not "give 2L NS" - activate MTP)
  D → Disability (GCS, pupils)
  E → Exposure + environment (cut off all clothes, warm)
         ↓
SIMULTANEOUS ACTIONS (first 5 minutes)
  • Activate MTP if: transient/non-responder, SBP < 90,
    HR > 120, penetrating, FAST+
  • TXA if not given prehospital (< 3h window!)
  • Start 1:1:1 blood products - NO crystalloid boluses
  • Warm ALL blood products via fluid warmer
  • FAST exam + portable CXR + pelvic XR
  • Calcium chloride 1g IV
  • Permissive hypotension: target SBP 80-90
    (unless TBI → maintain MAP > 80)
         ↓
HEMORRHAGE CONTROL
  • FAST positive → OR (damage control laparotomy)
  • Pelvic fracture → IR (angioembolization) or pelvic packing
  • Chest hemorrhage → thoracostomy / thoracotomy
  • REBOA (Zone I or III) if available and indicated
         ↓
MONITOR & TITRATE
  • ABG: pH, lactate, base deficit, Ca++, Hgb
  • TEG/ROTEM → transition to goal-directed therapy
  • Temperature: active warming
  • De-escalate MTP when hemostasis confirmed
         ↓
POST-HEMOSTASIS: Switch to Perfusion-Targeted Resuscitation
  • Now target MAP > 65 (or > 80 if TBI)
  • Adequate preload and afterload
  • Thromboprophylaxis (24-48h post injury)
  • Abdominal compartment pressure monitoring

9. Special Populations and Exceptions

Population	Modification
TBI	NO permissive hypotension; MAP > 80 mmHg; target normocapnia; avoid hyponatremia
Elderly	Higher baseline BP; "normal" SBP 100-120 may be relatively hypotensive; lower threshold for MTP
Anticoagulated patients	4-factor PCC to reverse anticoagulation rapidly; reversal agent if DOAC-related
Pediatrics	TXA: if used, within 3h of injury; weight-based blood product dosing; no standardized MTP threshold
Pregnancy	Higher baseline blood volume; fetal monitoring; uterine displacement; 1:1:1 applies
Penetrating cardiac	ED thoracotomy if signs of life lost within 15 min in penetrating; 1:1:1 + aortic cross-clamp

10. Abdominal Compartment Syndrome (ACS) - The Complication of Over-Resuscitation

Paradoxically, DCR also helps PREVENT ACS - which was common with aggressive crystalloid resuscitation.

Definition: Sustained intra-abdominal pressure (IAP) > 20 mmHg + new organ dysfunction
Intra-abdominal hypertension: IAP ≥ 12 mmHg
Measure via: Foley catheter - transduced bladder pressure
Manifestations: Oliguria, hypoxia (elevated diaphragm), cardiac failure, ileus
Treatment: Decompressive laparotomy with temporary abdominal closure (wound VAC)

The incidence of ACS is falling with adoption of DCR - confirming crystalloids as the iatrogenic driver. - Mulholland & Greenfield's Surgery, 7th ed.

11. Key Evidence Base

Trial / Guideline	Finding
CRASH-2 (2010)	TXA ≤ 3h reduces mortality in hemorrhagic trauma; after 3h, increases mortality
PROPPR Trial (Holcomb, JAMA 2015)	1:1:1 vs 1:1:2 FFP:PLT:pRBC - improved 24h and 30d mortality; better hemostasis
PAMPer Trial (2018)	Prehospital FFP reduced 30-day mortality vs standard care
EAST PMG 2025 (PMID 40956301)	Strong evidence for TXA in injured patients at hemorrhagic risk
NAEMSP/ACEP/ACS-COT 2025 (PMID 40842057)	Prehospital TXA reduces mortality; 1g+1g or 2g dose within 3h
TEG/ROTEM meta-analysis (PMID 33769424)	Viscoelastic testing guides DCR more precisely than standard labs
AAST/ACS Protocol 2024	Evidence-based DCR protocol: hemorrhage control + hypotensive resuscitation + hemostatic products + adjuncts

12. Common Pitfalls

Pitfall	Consequence	Fix
"2L NS first" reflex	Dilutional coagulopathy, worsens lethal triad	Activate MTP, give blood products instead
Delaying TXA while waiting for labs	Missed 3-hour window = no benefit or harm	Give TXA at triage if mechanism + hemodynamic instability
Permissive hypotension in TBI	Cerebral herniation, secondary injury	Target MAP > 80 in confirmed or suspected TBI
Treating acidosis with bicarbonate	Worsens cellular acidosis, no outcome benefit	Fix perfusion (stop bleeding, restore blood)
Giving saline for hypocalcemia	Hyperchloremic acidosis	Use calcium chloride
Rewarming too slowly	Coagulopathy persists despite products	Warm fluids, warm room, external warmers from the start
Over-resuscitating post-hemostasis	Abdominal compartment syndrome, pulmonary edema	Transition to guided, restrictive resuscitation after hemostasis
Continuing 1:1:1 after bleeding controlled	Unnecessary blood product exposure	Switch to TEG/ROTEM-guided therapy

Sources:

Mulholland & Greenfield's Surgery, 7th ed. - lethal triad, DCR components, TEG/ROTEM, endpoints
Bailey and Love's Short Practice of Surgery, 28th ed. - four DCR pillars, DCR diagram
Sabiston Textbook of Surgery, Biological Basis (latest ed.) - DCR components, origins
Morgan & Mikhail's Clinical Anesthesiology, 7th ed. - DCS/DCR anesthesia perspective, TEG use
Rockwood & Green's Fractures in Adults, 10th ed. (2025) - DCR in orthopaedic trauma
AAST/ACS DCR Clinical Protocol 2024 - evidence-based DCR recommendations
NAEMSP/ACEP/ACS-COT TXA Position Statement 2025 (PMID 40842057) - prehospital TXA guidance
EAST PMG TXA 2025 (PMID 40956301) - systematic review + practice guideline
TEG/ROTEM Systematic Review (PMID 33769424) - viscoelastic testing in DCR
ATLS 11th edition (2025) - xABCDE, DCR formalized

This is a shared conversation. Sign in to Orris to start your own chat.